These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6526396)

  • 1. Urinary metabolic profile of isoniazid in patients who develop isoniazid-related liver damage.
    Timbrell JA; Wright JM
    Hum Toxicol; 1984 Dec; 3(6):485-95. PubMed ID: 6526396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis.
    Mitchell JR; Zimmerman HJ; Ishak KG; Thorgeirsson UP; Timbrell JA; Snodgrass WR; Nelson SD
    Ann Intern Med; 1976 Feb; 84(2):181-92. PubMed ID: 766682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis.
    Grönhagen-Riska C; Hellstrom PE; Fröseth B
    Am Rev Respir Dis; 1978 Sep; 118(3):461-6. PubMed ID: 707874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased incidence of isoniazid hepatitis in rapid acetylators: possible relation to hydranize metabolites.
    Mitchell JR; Thorgeirsson UP; Black M; Timbrell JA; Snodgrass WR; Potter WZ; Jollow HR; Keiser HR
    Clin Pharmacol Ther; 1975 Jul; 18(1):70-9. PubMed ID: 1149365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylation rates and monthly liver function tests during one year of isoniazid preventive therapy.
    Mitchell JR; Long MW; Thorgeirsson UP; Jollow DJ
    Chest; 1975 Aug; 68(2):181-90. PubMed ID: 1080096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoniazid toxicity. A prospective study in secondary chemoprophylaxis.
    Byrd CB; Nelson R; Elliott RC
    JAMA; 1972 Jun; 220(11):1471-3. PubMed ID: 5067581
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the role of acetylhydrazine in isoniazid hepatotoxicity.
    Timbrell JA
    Arch Toxicol Suppl; 1979; (2):1-8. PubMed ID: 288324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoniazid chemoprophylaxis. Association with detection and incidence of liver toxicity.
    Byrd RB; Horn BR; Griggs GA; Solomon DA
    Arch Intern Med; 1977 Sep; 137(9):1130-3. PubMed ID: 332099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoniazid hepatotoxicity and acetylation during tuberculosis chemoprophylaxis.
    Myles RK
    Am Rev Respir Dis; 1980 Sep; 122(3):505-6. PubMed ID: 6106445
    [No Abstract]   [Full Text] [Related]  

  • 10. Isoniazid-related hepatotoxicity: a study of the effect of rifampicin administration on the metabolism of acetylisoniazid in man.
    Jenner PJ; Ellard GA
    Tubercle; 1989 Jun; 70(2):93-101. PubMed ID: 2617692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetylation phenotype and hepatotoxicity in the treatment of tuberculosis in children.
    Martinez-Roíg A; Camí J; Llorens-Terol J; de la Torre R; Perich F
    Pediatrics; 1986 Jun; 77(6):912-5. PubMed ID: 3487069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical hepatotoxicity of isoniazid in children.
    Stein MT; Liang D
    Pediatrics; 1979 Oct; 64(4):499-505. PubMed ID: 492816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of isoniazid inactivators by dilution test.
    Hodgkin MM; Eidus L; Hamilton EJ
    Bull World Health Organ; 1974; 51(4):428-30. PubMed ID: 4549494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver damage and isoniazid allergy.
    Assem ES; Ndoping N; Nicholson H; Wade JR
    Clin Exp Immunol; 1969 Oct; 5(4):439-42. PubMed ID: 5359962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoniazid hepatitis.
    Maddrey WC; Boitnott JK
    Ann Intern Med; 1973 Jul; 79(1):1-12. PubMed ID: 4721174
    [No Abstract]   [Full Text] [Related]  

  • 16. Association of isoniazid-metabolizing enzyme genotypes and isoniazid-induced hepatotoxicity in tuberculosis patients.
    Sotsuka T; Sasaki Y; Hirai S; Yamagishi F; Ueno K
    In Vivo; 2011; 25(5):803-12. PubMed ID: 21753138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoniazid-associated hepatitis. Report of an outbreak.
    Garibaldi RA; Drusin RE; Ferebee SH; Gregg MB
    Am Rev Respir Dis; 1972 Sep; 106(3):357-65. PubMed ID: 5080707
    [No Abstract]   [Full Text] [Related]  

  • 18. Three months of weekly rifapentine plus isoniazid is less hepatotoxic than nine months of daily isoniazid for LTBI.
    Bliven-Sizemore EE; Sterling TR; Shang N; Benator D; Schwartzman K; Reves R; Drobeniuc J; Bock N; Villarino ME;
    Int J Tuberc Lung Dis; 2015 Sep; 19(9):1039-44, i-v. PubMed ID: 26260821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoniazid hepatotoxicity in children.
    Rapp RS; Campbell RW; Howell JC; Kendig EL
    Am Rev Respir Dis; 1978 Oct; 118(4):794-6. PubMed ID: 309296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxic effects of isoniazid in tuberculosis chemoprophylaxis. Role of biochemical monitoring in 1,000 patients.
    Byrd RB; Horn BR; Solomon DA; Griggs GA
    JAMA; 1979 Mar; 241(12):1239-41. PubMed ID: 762788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.